NCT06686173View on ClinicalTrials.gov

Effect of Donor Chose on the Outcomes of GVHD Prophylaxis Underwent the Combined Treatment of ATG/PTCy for Haplo-HSCT

Not yet recruitingOBSERVATIONAL
Enrollment

114

Participants

Timeline

Start Date

February 1, 2025

Primary Completion Date

February 1, 2027

Study Completion Date

February 1, 2028

Conditions
High-Risk Acute Myeloid LeukemiaRelapse And/or Refractory AML
Interventions
OTHER

None-placebo

This is one kind descriptive study. The different donor groups made the cohorts different: the parous female donor and young male donor

OTHER

non-intervention study

This study is one kind of non intervention study

OTHER

donor selection

the intervention of this study was the different donor groups: the parous female donor and young male donor. All the patients involved in this study were treated by the combination of ATG and PTCy

All Listed Sponsors
lead

Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine

OTHER

NCT06686173 - Effect of Donor Chose on the Outcomes of GVHD Prophylaxis Underwent the Combined Treatment of ATG/PTCy for Haplo-HSCT | Biotech Hunter | Biotech Hunter